The American Stroke Association (ASA) assembled a multidisciplinary group of experts to develop recommendations regarding the potential effectiveness of establishing an identification program for ...stroke centers and systems. "Identification" refers to the full spectrum of models for assessing and recognizing standards of quality care (self-assessment, verification, certification, and accreditation). A primary consideration is whether stroke center identification might improve patient outcomes.
In February 2001, ASA, with the support of the Stroke Council's Executive Committee, decided to embark on an evaluation of the potential impact of stroke center identification. HealthPolicy R&D was selected to prepare a comprehensive report. The investigators reported on models outside the area of stroke, ongoing initiatives within the stroke community (such as Operation Stroke), and state and federal activities designed to improve care for stroke patients. The investigators also conducted interviews with thought leaders in the stroke community, representing a diverse sampling of specialties and affiliations. In October 2001, the Advisory Working Group on Stroke Center Identification developed its consensus recommendations. This group included recognized experts in neurology, emergency medicine, emergency medical services, neurological surgery, neurointensive care, vascular disease, and stroke program planning.
There are a variety of existing identification programs, generally falling within 1 of 4 categories (self-assessment, verification, certification, and accreditation) along a continuum with respect to intensity and scope of review and consumption of resources. Ten programs were evaluated, including Peer Review Organizations, trauma centers, and new efforts by the National Committee on Quality Assurance and the Joint Commission on the Accreditation of Healthcare Organizations to identify providers and disease management programs. The largest body of literature on clinical outcomes associated with identification programs involves trauma centers. Most studies support that trauma centers and systems lead to improved mortality rates and patient outcomes. The Advisory Working Group felt that comparison to the trauma model was most relevant given the need for urgent evaluation and treatment of stroke. The literature in other areas generally supports the positive impact of identification programs, although patient outcomes data have less often been published. In the leadership interviews, participants generally expressed strong support for pursuing some form of voluntary identification program, although concerns were raised that this effort could meet with some resistance.
Identification of stroke centers and stroke systems competencies is in the best interest of stroke patients in the United States, and ASA should support the development and implementation of such processes. The purpose of a stroke center/systems identification program is to increase the capacity for all hospitals to treat stroke patients according to standards of care, recognizing that levels of involvement will vary according to the resources of hospitals and systems.
It is no surprise that the US leads the world in medical innovation. Between 1969 and 2008, Americans received 57 Nobel Prizes in Medicine and Physiology, compared with 40 prizes received by European ...Union, Japan, Canada, Switzerland and Australia scientists combined. The private incentive system combined with the American trait of seeing failures as a step toward new solutions has created an innovation environment. Along with scientific discovery and biomedical understanding, companies must master another layer of essential knowledge -- how to comply with the myriad of legal, regulatory, monitoring and risk-management requirements of government agencies, says Timothy Wright, president of Covidien's Pharmaceuticals segment.
SOCIAL ETIQUETTE Bashe, Gil
Medical Marketing and Media,
10/2008, Letnik:
43, Številka:
10
Trade Publication Article
Accessibility of online product and disease-state information has paved the way for a new era of patient interaction -- and a new era in branding and communications. Just as pharma followed other ...industries into customer-relationship management (CRM), industry is following other sectors into Web 2.0 and using the Web to reinforce compliance messaging. Moderators on GlaxoSmithKline's (GSK's) Alli Circles Community counsel that Alli is a program and requires patients to rethink eating habits, choose food with lower fat content, eat three meals a day, do physician activity and not to take anti-diarrhea meds -- steps designed to manage side effects. Quest Diagnostics has used Web 2.0 in its aim to up compliance with annual colorectal cancer screening. If pharma can fashion itself as a partner in health, providing all supplementary information to guide fair-balance choices and the path to living well, it's going to loom large in the minds of consumers.
Driven by the quest for innovation, the intensity of competition, and the pressure to create megabrands and megamergers, pharmaceutical executives are exploring an influential force still untapped by ...most marketing and communication departments - the power of emotion. Since embracing direct-to-consumer advertising four years ago, the industry has turned from selling "product attributes" to creating "customer experiences." That shift enables marketers to combine the best of "product IQ" - clinical efficacy - and "brand EQ" - emotional connection with customers. Integration of those assets is a product manager's key to establishing a franchise customer relationship management system and unleashing the power of what authors Scott Robinette and Claire Brand call "emotion marketing" in their book of the same name.
Direct to consumer--or customer? Bashe, Gil
Pharmaceutical Executive,
05/2001, Letnik:
21, Številka:
5
Trade Publication Article
Although FDA continues to dissect the content of direct-to-consumer advertising and public advocacy pundits question the value of consumer-targeted Rx promotion, the DTC genie will not be forced back ...into the bottle. Its long-term role in the pharma marketing mix is secure. The dialogue has shifted from questioning the medium's legitimacy to exploring its content.
Global branding challenge Bashe, Gil
Pharmaceutical Executive,
06/2000, Letnik:
20, Številka:
6
Trade Publication Article
The world of pharmaceutical branding is very complex. In fact, the consumer puzzle is so fragmented there, it seems almost impossible to piece together. Customer needs vary, regulatory approval ...systems are nation- or state-based, identical drug molecules are sold under multiple brand names, free-market economy and therapeutic price referencing co-exist, and a web of consumers exerts special influence. The only common element is the product molecule. There is no easy way for pharmaceutical products to convey a single global brand message. An article describes the imperatives of the changing marketplace and describes how pharma companies can become "knowledge brokers" that integrate the complexities of the global market with the needs of the consumer. Guidelines are presented.
The flood of misperceptions- driven by political agendas, individualism, and a disinformation campaign about vaccine safety, risks, and side effects-required state governments to create "myth-buster ...websites" to counter the confusion. Traditionally, public education campaigns have been critical to fighting pandemics and scourges like polio ever since public health authorities began their work in the nineteenth century. Federal and state public health leaders and vaccination site managers need to agree on messaging and speak with one voice.
Celotno besedilo
Dostopno za:
DOBA, IZUM, KILJ, NUK, PILJ, PNG, PRFLJ, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK
PDF
